Applications of molecular methods for Leishmania control

Expert Review of Molecular Diagnostics

Volumn 5, Issue 2, 2005, Pages 251-265

  Singh, Sarman ^a   Dey, Ayan ^a   Sivakumar, Ramu ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Drug targeting; Gene expression profiling; Gene sequencing; Letshmania; Microarrays; PCR; Recombinant antigens; Vaccine

Indexed keywords

AMPHOTERICIN B; ANTIMONY GLUCONATE; KINESIN; PEPTIDE NUCLEIC ACID; RECOMBINANT ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGGLUTINATION TEST; AMASTIGOTE; AMPLIFIED RIBOSOMAL DNA RESTRICTION ANALYSIS; ANTIBODY DETECTION; ANTIGEN DETECTION; DIAGNOSTIC ACCURACY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENOME; HOST PARASITE INTERACTION; HUMAN; IMMUNOBLOTTING; LATEX AGGLUTINATION TEST; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIASIS; MOLECULAR CLONING; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; PARASITE CONTROL; PARASITOLOGY; POLYMERASE CHAIN REACTION; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKIN LEISHMANIASIS; SKIN TEST; STRAIN IDENTIFICATION; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIGENS, PROTOZOAN; GENE EXPRESSION PROFILING; GENOME, PROTOZOAN; HOST-PARASITE RELATIONS; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MOLECULAR DIAGNOSTIC TECHNIQUES; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, DNA; VACCINES;

EID: 15444369728     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.2.251     Document Type: Review

References (92)

1. Herwaldt BL. Leishmaniasis. Lancet 354(9185), 1191-1199 (1999). •• Comprehensive review covering parasitology, epidemiology, clinical manifestations with variations, diagnosis and treatment.
2. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. 95(3), 239-243 (2001).
3. Ashford RW, Bates PA. Leishmaniasis in the Old World. In: Topey & Wilson's Microbiology and Microbial Infections (volume 5), ninth edition. Parasitology. Cox FEG, Kreier JP, Wakelin D (Eds), Oxford University Press, NY, USA, 215-240 (1998).
4. Lainson R, Shaw JJ. New World leishmaniasis - The Neotropical Leishmania species. In: Topey & Wilson's Microbiology and Microbial Infections (volume 5), ninth edition. Parasitology. Cox FEG, Kreier JP, Wakelin D (Eds). Oxford University Press, NY, USA, 241-282(1998).
5. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis: review. J. Infect. Chemother. 10(6), 307-315 (2004). • Provides up-to-date information on antileishmanial treatment.
6. Singh S. Diagnostic and prognostic markers of antikala-azar therapy and vaccination. In: Proceeding of V Round Table Conference Series. No. 5. Gupta S, Sood OP (Eds), Ranbaxy Science Foundation, New Delhi, India, 95-114 (1999).
7. Kafetzis DA. An overview of pediatric leishmaniasis. J. Postgrad. Med. 49, 31-38 (2003). •• Comprehensive review on pediatric leishmaniasis.
8. Mauricio IL, Stothard JR, Miles MA. The strange case of Leishmania chagasi. Parasitol. Today 16, 188-189 (2000).
9. Tavares CAP, Fernandes AP, Melo MN. Molecular diagnosis of leishmaniasis. Expert Rev. Mol. Diagn. 3(5), 657-667 (2003). •• Comprehensive review providing updates up to 2003.
10. Sharma RC, Mahajan VK, Sharma NC, Sharma A. A new focus of cutaneous leishmaniasis in Himachal Pradesh (India). Indian J. Dermatol. Venerol. Leprol. 69, 170-172 (2003).
11. Amaral V, Pirmez C, Goncalves A, Ferreira V, Grimaldi G Jr. Cell populations in lesions of cutaneous leishmaniasis of Leishmania (L.) amazonensis-infected rhesus macaques, Macaca mulatta. Mem. Inst. Oswaldo Cruz. 95(2), 209-216 (2000).
12. Ahluwalia S, Lawn SD, Kanagalingam J, Grant H, Lockwood DN. Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America. Br. Med. J. 329(7470), 842-844 (2004).
13. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kalaazar-dermal-leiishmaniasis. Lancet Infect. Dis. 3(2), 87-98 (2003). •• Concise review on post-kala-azar-dermal leishmaniasis describing various clinical forms of post-kala-azar-dermal leishmaniasis and its management.
14. Victoir K, Dujardin J-C. How to succeed in parasitic life without sex? Asking Leishmania. Trends Parasitol. 18(2), 81-85 (2002).
15. Sivakumar R. Studies on the kinesin related antigen gene of Leishmania donovani and its diagnostic application. All India Institute of Medical Sciences, New Delhi, India, PhD Thesis (2004).
16. Singh S, Sivakumar R. Recent advances in the diagnosis of leishmaniasis. J. Postgrad. Med. 49(1), 55-60 (2003).
17. Paredes R, Munoz J, Diaz I, Domingo P, Gurgui M, Clotet B. Leishmania in HIV Infection. J. Postgrad. Med. 49(1), 39-49 (2003). •• Comprehensive review on Leishmania-HIV coinfection.
18. Singh S, Singh N, Handa R. High serum levels of TNF in malaria and kala-azar. J. Assoc. Physic. India 45, 526-529 (1997).
19. Liarte DB, Mendonca IL, Luz FCO et al. QBC® for the diagnosis of human and canine American visceral leishmaniasis: preliminary data. Rev. Soc. Bras. Med. Trop. 34, 577-581 (2001).
20. Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 9(5), 951-958 (2002).
21. Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32(3), 475-479 (1983).
22. Boelaert M, Rijal S, Regmi S et al. Comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. Am. J. Trop. Med. Hyg. 70(1), 72-77 (2004).
23. Schallig HD, Schoone GJ, Kroon CC, Hailu A, Chappuis F, Veeken H. Development and application of 'simple' diagnostic tools for visceral leishmaniasis. Med. Microbiol. Immunol. (Berl.) 190(1-2), 69-71 (2001).
24. Iqbal J, Hira PR, Saroj G et al. Imported visceral leishmaniasis: diagnostic dilemmas and comparative analysis of three assays. J. Clin. Microbiol. 40(2), 475-479 (2002).
25. Abdallah KA, Nour BY, Schallig HD et al. Evaluation of the direct agglutination test based on freeze-dried Leishmania donovani promastigotes for the serodiagnosis of visceral leishmaniasis in Sudanese patients. Trop. Med. Int. Health 9(10), 1127-1131 (2004).
26. Schoone GJ, Hailu A, Kroon CC, Nieuwenhuys JL, Schallig HD, Oskam L. A fast agglutination-screening test (FAST) for the detection of antiLeishmania antibodies. Trans. R. Soc. Trop. Med. Hyg. 95(4), 400-401 (2001).
27. Palatnik-de-Sousa CB, Gomes EM, Paraguai-de-Souza E, Palatnik M, Luz K, Borojevic R. Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 89(4), 390-393 (1995).
28. Maalej IA, Chenik M, Louzir H et al. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68(3), 312-320 (2003). • Reports sensitivity, specificity, positive and negative predictive values of various antigens reported until 2002.
29. Martin SK, Thuita-Harun L, Adoyo-Adoyo M, Wasunna ICM. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes. Ann. Trop. Med. Parasitol. 92(5), 571-577 (1998).
30. Jensen AT, Gasim S, Moller T et al. Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Trans. R. Soc. Trop. Med. Hyg. 93(2), 157-160 (1999).
31. Raj VS, Ghosh A, Dole VS, Madhubala R, Myler PJ, Stuart KD. Serodiagnosis of leishmaniasis with recombinant ORFF antigen. Am. J. Trop. Med. Hyg. 61(3), 482-487 (1999).
32. Singh S, Kumari V, Singh N. Predicting Kala-Azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin. Diagn. Lab. Immunol. 9, 568-572 (2002).
33. Zijlstra EE, Nur Y, Desjeux P Khalil EA, El-Hassan AM, Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop. Med. Int. Health 6(2), 108-113 (2001).
34. Jelinek T, Eichenlaub S, Loscher T. Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. Eur. J. Clin. Microbiol. Infect. Dis. 18(9), 669-670 (1999).
35. Schallig HD, Canto-Cavalheiro M, da Silva ES. Evaluation of the direct agglutination test and the rK39 dipstick test for the sero-diagnosis of visceral leishmaniasis. Mem. Inst. Oswaldo. Cruz. 7, 1015-1018 (2002).
36. Carvalho SF, Lemos EM, Corey R, Dietze R. Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68(3), 321-324 (2003).
37. Bhatia A, Daifalla NS, Jen S, Badaro R, Reed SG, Skeiky YA. Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol. Biochem. Parasitol. 102(2), 249-261 (1999).
38. Ravindran R, Anam K, Bairagi BC et al. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy. Infect. Immun. 72(2), 863-670 (2004).
39. Attar ZJ, Chance ML, el-Safi S et al. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop. 78(1), 11-16 (2001).
40. Sreenivas G, Ansari NA, Singh R et al. Diagnosis of visceral leishmaniasis: comparative potential of amastigote antigen, recombinant antigen and PCR. Br. J. Biomed. Sci. 59(4), 218-222 (2002).
41. Schallig HD, Oskam L. Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Trop. Med. Int. Health 7(8), 641-651 (2002).
42. da Silva ES, Gontijo CM, Pacheco Rda S, Brazil RP. Diagnosis of human visceral leishmaniasis by PCR using blood samples spotted on filter paper. Genet. Mol. Res. 3(2), 251-257 (2004).
43. El Tai NO, El Fari M, Mauricio I et al. Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Exp. Parasitol. 97(1), 35-44 (2001).
44. Pizzuto M, Piazza M, Senese D et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients co-infected with human immunodeficiency virus Type 1. J. Clin. Microbiol. 39(1), 357-361 (2001).
45. Wortman G, Sweeney C, Houng H-S et al. Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction. Am. J. Trop. Med. Hyg. 65, 583-587 (2001).
46. Monroy Ostria, Sanchez-Tezeda G. Molecular probes and the polymerase chain reaction for detection and typing of Leishmania species in Mexico. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1), S101-S104 (2002).
47. Chiurillo MA, Sachdeva M, Dole VS et al. Detection of Leishmania causing visceral leishmaniasis in the Old and New Worlds by a polymerase chain reaction assay based on telomeric sequences. Am. J. Trop. Med. Hyg. 65(5), 573-582 (2001).
48. Davila AM, Momen H. Internaltranscribed-spacer (ITS) sequences used to explore phylogenetic relationships within Leishmania Ann. Trop. Med. Parasitol 94(6), 651-654 (2000).
49. Marfurt J, Niederwieser I, Makia ND, Beck HP, Felger I. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn. Microbiol. Infect. Dis. 46(2), 115-124 (2003).
50. Gangneux JP, Menotti J, Lorenzo F et al. Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of nonendemicity. J. Clin. Microbiol. 41(4), 1419-1422 (2003). • Reports that isoenzyme characterization and PCR-sequencing have 100% concordance.
51. Schonian G, El Fari M, Lewin S, Schweynoch C, Presber W. Molecular epidemiology and population genetics in Leishmania Med. Microbiol. Immunol. (Berl.) 190(1-2), 61-63 (2001).
52. Martin-Sanchez J, Pineda JA, Morillas-Marquez F, Garcia-Garcia JA, Acedo C, Macias J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am. J. Trop. Med. Hyg. 70(5), 545-548 (2004).
53. Otero AC, da Silva VO, Luz KG et al. Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am. J. Trop. Med. Hyg. 62(1), 128-131 (2000).
54. Gannavaram S, Ansari NA, Kataria J, Salotra P. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post kala-azar dermal leishmaniasis lesions. J. Clin. Microbiol. 42, 1777-1778 (2004).
55. Strauss-Ayali D, Jaffe VL, Burshtain O, Gonen L, Baneth G. Polymerase chain reaction using noninvasively obtained samples, for the detection of Leishmania infantum DNA in dogs. J. Infect. Dis. 189(9), 1729-1733 (2004). • Reports the high sensitivity of PCR and its field application.
56. de Oliveira CI, Bafica A, Oliveira F et al. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin. Infect. Dis. 37(11), E149-E153 (2003).
57. Matsumoto T, Hashiguchi Y, Gomez EA et al. Comparison of PCR results using scrape/exudate, syringe-sucked fluid and biopsy samples for diagnosis of cutaneous leishmaniasis in Ecuador. Trans. R. Soc. Trop. Med. Hyg, 93(6), 606-607 (1999).
58. Mimori T, Matsumoto T, Calvopina MH et al. Usefulness of sampling with cotton swab for PCR-diagnosis of cutaneous leishmaniasis in the New World. Acta Trop. 81(3), 197-202 (2002).
59. Pirmez C, da Silva Trajano V, Paes-Oliveira Neto M et al. Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil. J. Clin. Microbiol. 37(6), 1819-1823 (1999).
60. Pinero J, Martinez E, Pacheco R et al. PCR-ELISA for diagnosis of mucocutaneous leishmaniasis. Acta Trop. 73(1), 21-29 (1999).
61. Victoir K, de Doncker S, Cabrera L et al. Direct identification of Leishmania species in biopsies from patients with American tegumentary leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 97(1), 80-87 (2003).
62. Volpini AC, Passos VM, Oliveira GC, Romanha AJ. PCR-RFLP to identify Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis causing American cutaneous leishmaniasis. Acta Trop. 90(1), 31-37 (2004).
63. el Tai NO, Osman OF, el Fari M, Presber W, Schonian G. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single strand conformation polymorphisms and sequencing. Trans. R. Soc. Trop. Med. Hyg. 94, 575-579 (2000).
64. Schulz A, Mellenthin K, Schonian G, Fleischer B, Drosten C. Detection, differentiation, and quantitation of pathogenic Leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J. Clin. Microbiol. 41, 1529-1535 (2003). •• Reports the modifications in the PCR protocol to detect, differentiate and quantitate the Leishmania.
65. Harris E, Kropp G, Belli A, Rodriguez B, Agabian N. Single-step multiplex PCR assay for characterization of New World Leishmania complexes. J. Clin. Microbiol. 36(7), 1989-1995 (1998).
66. Belli A, Rodriguez B, Aviles H, Harris E. Simplified polymerase chain reaction detection of new world Leishmania in dinical specimen of cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 58(1), 102-109 (1998).
67. Lewin S, Schonian G, El Tai N, Oskam L, Bastien P, Presber W. Strain typing in Leishmania donovani by using sequence-confirmed amplified region analysis. Int. J. Parasitol. 32(10), 1267-1276 (2002).
68. Mauricio IL, Stothard JR, Miles MA. Leishmania donovani complex: genotyping with the ribosomal internal transcribed spacer and the mini-exon. Parasitology 128(Pt 3), 263-267 (2004).
69. Martinez E, Alonso V, Quispe A et al. RAPD method useful for distinguishing Leishmania species: design of specific primers for L. braziliensis. Parasitology 127(Pt 6), 513-517 (2003).
70. Williams JG, Hanafey MK, Rafalski JA, Tingey SV. Genetic analysis using random amplified polymorphic DNA markers. Methods Enxymol. 218, 704-740 (1993).
71. Hanafi R, Barhoumi M, Ali SB, Guizani I. Molecular analyses of Old World Leishmania RAPD markers and development of a PCR assay selective for parasites of the L. donovani species complex. Exp. Parasitol. 98(2), 90-99 (2001).
72. Deniau M, Canavate C, Faraut-Gambarelli F, Marty P. The biological diagnosis of leishmaniasis in HIV-infected patients. Ann. Trop. Med. Parasitol. 297 (Suppl. 1), 115-133 (2003).
73. Bossolasco S, Gaiera G, Olchini D et al. Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J. Clin. Microbiol. 41(11), 5080-5084 (2003).
74. Cruz I, Morales MA, Noguer I, Rodriguez A, Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet 359(9312), 1124-1125 (2002).
75. Croft SL. Monitoring drug resistance in leishmaniasis. Trop. Med. Intern. Health 6, 899-905 (2001).
76. Disch J, Oliveira MC, Orsini M, Rabello A. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis. Acta Trop. 92(3), 279-283 (2004).
77. Mendonca MG, de Brito ME, Rodrigues EH, Bandeira V, Jardim ML, Abath FG. Persistence of Leishmania parasites in scars after Clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 189(6), 1018-1023 (2004).
78. Singh N, Singh RT, Sundar S. Novel mechanism of drug resistance in kala-azar field isolates. J. Infect. Dis. 188(4), 600-607 (2003).
79. Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J. Clin. Microbiol. 42(11), 5249-5255 (2004).
80. Schoone GJ, Oskam L, Kroon NCM, Schallig HDFH, Omar SA. Detection and quantification of Plasmodium falciparum blood samples using quantitative nucleic acid sequence-based amplification. J. Clin. Microbiol. 38, 4072-4075 (2000).
81. Nimri LF, Schallig HD. Application of riboprinting for the identification of isolates of cutaneous Leishmania spp. Parasitology 127(Pt 3), 201-215 (2003).
82. Radwanska M, Magez S, Perry-O'Keefe H et al. Direct detection and identification of African trypanosomes by fluorescence in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 40(11), 4295-4297 (2002). • Reports application of peptide nucleic acid fluorescence in situ hybridization.
83. Myler PJ, Stuart KD. Recent developments from the Leishmania genome project. Curr. Opin. Microbiol. 3(4), 412-416 (2000).
84. Sunkin SM, Kiser P, Myler PJ et al. The size difference between Leishmania major Friedlin chromosome one homologues is localized to sub-telomeric repeats at one chromosomal end. Mol. Biochem. Parasit. 109, 1-15 (2000).
85. Zhou S, Kile A, Kvikstad E et al. Shotgun optical mapping of the entire Leishmania major Friedlin genome. Mol. Biochem. Parasitol. 138(1), 97-106 (2004).
86. Valenzuela JG, Garfield M, Rowton ED, Pham VM. Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J. Exp. Biol. 207(Pt 21), 3717-3729 (2004).
87. de Sousa JM, Lareau SM, Pearson RD, Carvalho EM, Mann BJ, Jeronimo SM. Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target. Scand. J. Infect. Dis. 35(11-12), 826-829 (2003).
88. Duncan RC, Salotra P, Goyal N, Akopyants NS, Beverley SM, Nakhasi HL. The application of gene expression microarray technology to kinetoplastid research. Curr. Mol. Med. 4(6), 611-621 (2004). •• Recent review on the application of functional genomics of Leishmania.
89. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Genet. 21(1 Suppl.), 33-37 (1999).
90. Beverley SM, Akopyants NS, Goyard S et al. Putting the Leishmania genome to work: functional genomics by transposon trapping and expression. Phil. Trans. R. Soc. Lond. 357, 47-53 (2002).
91. Radtke OA, Kiderlen AF, Kayser O, Kolodziej H. Gene expression profiles of inducible nitric oxide synthase and cytokines in Leishmania major-infected macrophage-like RAW 264.7 cells treated with gallic acid. Planta. Med. 70(10), 924-928 (2004).
92. Robinson KA, Beverley SM. Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol. Biochem. Parasitol. 128(2), 217-228 (2003).